石美智, 刘煜, 卞佳琳, 金梦, 贵春山. 天然产物与有机阴离子转运多肽1B1相互作用的研究J. 药学学报, 2015,50(7): 848-853.
引用本文: 石美智, 刘煜, 卞佳琳, 金梦, 贵春山. 天然产物与有机阴离子转运多肽1B1相互作用的研究J. 药学学报, 2015,50(7): 848-853.
SHI Mei-zhi, LIU Yu, BIAN Jia-lin, JIN Meng, GUI Chun-shan. The interactions between natural products and OATP1B1J. Acta Pharmaceutica Sinica, 2015,50(7): 848-853.
Citation: SHI Mei-zhi, LIU Yu, BIAN Jia-lin, JIN Meng, GUI Chun-shan. The interactions between natural products and OATP1B1J. Acta Pharmaceutica Sinica, 2015,50(7): 848-853.

天然产物与有机阴离子转运多肽1B1相互作用的研究

The interactions between natural products and OATP1B1

  • 摘要: 有机阴离子转运多肽1B1 (OATP1B1) 是一种重要的肝摄取转运蛋白, 介导许多内源性物质和药物转运进入肝细胞。为了鉴别和研究天然产物中潜在的OATP1B1调节剂, 本实验采用稳定表达OATP1B1的中国仓鼠卵巢细胞 (CHO-OATP1B1), 在96孔板中测定了21种常见天然化合物和提取物对OATP1B1介导荧光素甲氨蝶呤转运的影响。该方法可进一步运用于对化合物库的高通量筛选。本研究表明, 一些黄酮类化合物 (如槲皮素、槲皮苷、芦丁、菊花梗叶总黄酮和桑皮黄素等) 和三萜类化合物 (如甘草次酸和甘草酸等) 在体外对OATP1B1的功能有显著抑制作用, 其IC50值均小于16 μmol·L-1。甘草次酸的IC50值与其临床血药浓度相当, 预示其有可能引起OATP1B1介导的药物-药物相互作用。构效关系分析表明, 黄酮苷元比其相应的糖苷对OATP1B1的抑制作用更强, 而且糖的类型和糖链长度对其活性均有影响。此外, 以OATP1B1的底物氟伐他汀和罗伐他汀为探针药物, 体外研究了几种天然化合物对OATP1B1功能影响的底物依赖性。结果表明, 天然产物对OATP1B1转运功能的影响具有底物依赖性, 有助于预测和避免潜在的OATP1B1介导的不良药物-药物和药物-食物相互作用, 为临床合理用药提供实验依据和指导。

     

    Abstract: Organic anion transporting polypeptide 1B1 (OATP1B1) is an important liver-specific uptake transporter, which mediates transport of numerous endogenous substances and drugs from blood into hepatocytes. To identify and investigate potential modulators of OATP1B1 from natural products, the effect of 21 frequently used natural compounds and extracts on OATP1B1-mediated fluorescein methotrexate transport was studied by using Chinese hamster ovary cells stably expressing OATP1B1 (CHO-OATP1B1) in 96-well plates. This method could be used for the screening of large compound libraries. Our studies showed that some flavonoids (e.g., quercetin, quercitrin, rutin, chrysanthemum flavonoids and mulberrin) and triterpenoids (e.g., glycyrrhetinic acid and glycyrrhizic acid) were inhibitors of OATP1B1 with IC50 values less than 16 μmol·L-1. The IC50 value of glycyrrhetinic acid on OATP1B1 was comparable to its blood concentration in clinics, indicating an OATP1B1-mediated drug-drug interaction could occur. Structure-activity relationship analysis showed that flavonoids had much higher inhibitory activity than their glycosides. Furthermore, the type and length of saccharides had a significant effect on their activity. In addition, we used OATP1B1 substrates fluvastatin and rosuvastatin as probe drugs to investigate the substrate-dependent effect of several natural compounds on the function of OATP1B1 in vitro. Our results demonstrated that the effect of these natural products on the function of OATP1B1 was substrate-dependent. In summary, this study would be conducive to predicting and avoiding potential OATP1B1-mediated drug-drug and drug-food interactions and thus provide the experimental basis and guidance for rational drug use.

     

/

返回文章
返回